Hyperuricaemia: more than just a cause of gout?

被引:72
作者
Katsiki, Niki [1 ]
Karagiannis, Asterios [1 ]
Athyros, Vasilios G. [1 ]
Mikhailidis, Dimitri P. [2 ,3 ]
机构
[1] Aristotle Univ Thessaloniki, Hippocrat Hosp, Propedeut Dept Internal Med 2, GR-54006 Thessaloniki, Greece
[2] UCL, Sch Med, Dept Clin Biochem Vasc Dis Prevent Clin, London NW3 2QG, England
[3] UCL, Sch Med, Dept Surg, London NW3 2QG, England
关键词
cardiovascular disease; gout; metabolic syndrome; renal disease; uric acid; vascular risk; SERUM URIC-ACID; PERIPHERAL ARTERIAL-DISEASE; CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; INTIMA-MEDIA THICKNESS; FATTY LIVER-DISEASE; TYPE-2; DIABETES-MELLITUS; LOW-GRADE INFLAMMATION; METABOLIC SYNDROME; RISK-FACTORS;
D O I
10.2459/JCM.0b013e3283595adc
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Traditionally, serum uric acid (SUA) has been implicated in acute gouty arthritis or chronic gouty arthropathy. However, SUA also plays a role in other pathological conditions especially in cardiovascular (CV), metabolic and renal disease. This narrative review considers the significant associations of SUA with kidney function, several CV risk factors and vascular diseases, supporting the concept of assessing hyperuricaemia for reasons other than just gout. Several drugs that reduce CV risk also decrease SUA levels, further improving vascular risk. Therefore, selecting SUA-lowering drugs to treat high-risk patients may prove beneficial in terms of reducing CV risk.
引用
收藏
页码:397 / 402
页数:6
相关论文
共 141 条
  • [1] [Anonymous], COCHRANE DATABASE SY
  • [2] [Anonymous], INT J CARDIOL
  • [3] Effect of fenofibrate on kidney function:: A 6-week randomized crossover trial in healthy people
    Ansquer, Jean-Claude
    Dalton, R. Neil
    Causse, Elisabeth
    Crimet, Dominique
    Le Malicot, Karine
    Foucher, Christelle
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (06) : 904 - 913
  • [4] Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome - A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study
    Athyros, Vasilios G.
    Mikhailidis, Dimitri P.
    Liberopoulos, Evangelos N.
    Kakafika, Anna I.
    Karagiannis, Asterios
    Papageorgiou, Athanasios A.
    Tziomalos, Konstantinos
    Ganotakis, Emmanuel S.
    Elisaf, Moses
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (01) : 118 - 127
  • [5] Athyros VG, 2011, ARCH MED SCI, V7, P984, DOI [10.5114/AOMS.2011.26610, 10.5114/aoms.2011.26610]
  • [6] Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study
    Athyros, Vassilios G.
    Karagiannis, Asterios
    Ganotakis, Emmanouel S.
    Paletas, Konstantinos
    Nicolaou, Vassilios
    Bacharoudis, George
    Tziomalos, Konstantinos
    Alexandrides, Theodore
    Liberopoulos, Evangelos N.
    Mikhailidis, Dimitri P.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (08) : 1659 - 1668
  • [7] Pathogenesis and treatment of kidney disease and hypertension - Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study
    Athyros, VG
    Elisaf, M
    Papageorgiou, AA
    Symeonidis, AN
    Pehlivanidis, AN
    Bouloukos, VI
    Milionis, HJ
    Mikhailidis, DP
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) : 589 - 599
  • [8] Serum uric acid level and risk for peripheral arterial disease: Analysis of data from the multiple risk factor intervention trial
    Baker, Joshua F.
    Schumacher, H. Ralph
    Krishnan, Eswar
    [J]. ANGIOLOGY, 2007, 58 (04) : 450 - 457
  • [9] Association between Serum Uric Acid Levels and Diabetes Mellitus
    Bandaru, Pavani
    Shankar, Anoop
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2011, 2011
  • [10] Uric Acid as a Factor in the Metabolic Syndrome
    Borges, Rodolfo Leao
    Ribeiro, Artur Beltrame
    Zanella, Maria Teresa
    Batista, Marcelo Costa
    [J]. CURRENT HYPERTENSION REPORTS, 2010, 12 (02) : 113 - 119